Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 8.67 -1.48% -0.13
LBPH closed down 1.48 percent on Tuesday, July 27, 2021, on 49 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical LBPH trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 50 DMA Bullish -1.48%
1,2,3 Pullback Bullish Bullish Swing Setup -1.48%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.48%
Narrow Range Bar Range Contraction -1.48%
Oversold Stochastic Weakness -1.48%
Older End-of-Day Signals for LBPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 11 hours ago
50 DMA Resistance about 14 hours ago
50 DMA Support about 15 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 15 hours ago
1,2,3, Pullback Entry about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Psychiatry Epilepsy Neurology Amyotrophic Lateral Sclerosis Nervous System Neurophysiology Clinical Trial Product

Is LBPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.95
52 Week Low 7.39
Average Volume 69,823
200-Day Moving Average 0.00
50-Day Moving Average 8.79
20-Day Moving Average 9.02
10-Day Moving Average 8.74
Average True Range 0.75
ADX 46.24
+DI 46.72
-DI 8.81
Chandelier Exit (Long, 3 ATRs) 16.25
Chandelier Exit (Short, 3 ATRs) 10.75
Upper Bollinger Bands 9.72
Lower Bollinger Band 8.32
Percent B (%b) 0.25
BandWidth 15.56
MACD Line -0.09
MACD Signal Line -0.05
MACD Histogram -0.0415
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.02
Resistance 3 (R3) 9.02 8.92 8.96
Resistance 2 (R2) 8.92 8.83 8.91 8.94
Resistance 1 (R1) 8.79 8.77 8.86 8.79 8.92
Pivot Point 8.69 8.69 8.72 8.68 8.69
Support 1 (S1) 8.56 8.60 8.63 8.56 8.42
Support 2 (S2) 8.46 8.54 8.45 8.40
Support 3 (S3) 8.33 8.46 8.38
Support 4 (S4) 8.33